Previous close | 11.24 |
Open | 11.48 |
Bid | 11.38 x 1000 |
Ask | 11.45 x 300 |
Day's range | 11.28 - 11.50 |
52-week range | 8.24 - 13.24 |
Volume | |
Avg. volume | 7,057,513 |
Market cap | 9.179B |
Beta (5Y monthly) | 1.34 |
PE ratio (TTM) | 2.16 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Roivant Sciences' stock price is sensitive to their...
Roivant Sciences ( NASDAQ:ROIV ) Third Quarter 2024 Results Key Financial Results Revenue: US$37.1m (up 118% from 3Q...
Eric Venker, President & COO of Roivant Sciences Ltd (NASDAQ:ROIV), executed a sale of 96,950 shares in the company on February 9, 2024, according to a recent SEC Filing.